110336 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Gammaretrovirus, e.g. murine leukeamia virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
IMMUNOTHERAPEUTIC COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA MULTIFORME
#2FELINE LEUKEMIA VIRUS VACCINE
#3RECOMBINANT NEWCASTLE DISEASE VIRUS (rNDV) VECTORS AND METHODS OF USING THE SAME
#4Novel Adjuvant Compositions
#5SYNTHETIC DNA VACCINE IMMUNOGENIC IMPROVEMENTS
#6THYMIDINE KINASE GENE
#7Feline leukemia virus vaccine
#8Vaccine compositions for the treatment of coronavirus
#9Adjuvant compositions
#10T-CELL INDUCING VACCINE COMPOSITION COMBINATION AND USES THEREOF
#11Feline leukemia virus vaccine
#12IMMUNOTHERAPEUTIC COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA MULTIFORME
#13Method of inhibiting enveloped virus binding to target cells by incorporating P-selectin glycoprotein ligand-1 (PSGL-1) into virions
#14Thymidine kinase gene
#15Thymidine kinase diagnostic assay for gene therapy applications
#16Adjuvant compositions
#17Vaccine compositions for treatment of Zika virus
#18Thymidine kinase diagnostic assay for gene therapy applications
#19Thymidine kinase gene
#20Adjuvant compositions
#21Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#22Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#23Method for identifying and treating a patient having tumor lesions comprising administering a gene therapy retroviral vector particle comprising a mutated HSV-thymidine kinase (HSV-TK) polynucleotide
#24Thymidine kinase gene
#25Adjuvant compositions
#26Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#27Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#28Identification of a novel retrovirus in patients with benign prostatic hyperplasia
#29HIV-1 Envelope Polypeptides for HIV Vaccine
#30Inactivated FCV vaccines
#31Novel Compositions and Uses Thereof
#32Adjuvant compositions
#33Virus coated nanoparticles and uses thereof
#34Inactivated FCV vaccines
#35VIRAL VACCINE AND METHOD FOR PREPARATION THEREOF
#36Raccoon Poxvirus Expressing Genes of Feline Antigens
#37IGF-1 AS FELINE VACCINE ADJUVANT, IN PARTICULAR AGAINST FELINE RETROVIRUSES
#38Methods of inducing mucosal immunity
#39Materials and methods relating to DNA vaccination
#40Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
#41Inactivated FCV vaccines
#42Needle-free administration of FeLV vaccines
#43Vaccines containing a saponin and a sterol
#44Coronavirus-like particles comprising functionally deleted genomes
#45Vaccine compositions for treatment of Zika virus